Durect Corporation
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment… Read more
Durect Corporation (DRRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.447x
Based on the latest financial reports, Durect Corporation (DRRX) has a cash flow conversion efficiency ratio of -0.447x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.76 Million) by net assets ($3.94 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Durect Corporation - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Durect Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Durect Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Durect Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Daesung Energy
KO:117580
|
-0.031x |
|
Village Bank and Trust Financial
NASDAQ:VBFC
|
-0.037x |
|
Falcon Machine Tools Co Ltd
TWO:4513
|
-0.021x |
|
Weblink International Inc
TW:6776
|
-0.185x |
|
YASHO INDUSTRIES ORD (BSE)
NSE:YASHO
|
0.011x |
|
Nightingale Health Oyj B
HE:HEALTH
|
-0.153x |
|
ETHZilla Corporation
NASDAQ:ETHZ
|
-0.037x |
|
NANOFORM FINLAND OYJ
F:4YL
|
N/A |
Annual Cash Flow Conversion Efficiency for Durect Corporation (1999–2024)
The table below shows the annual cash flow conversion efficiency of Durect Corporation from 1999 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $9.13 Million | $-19.09 Million | -2.090x | +10.21% |
| 2023-12-31 | $14.78 Million | $-34.41 Million | -2.328x | -121.32% |
| 2022-12-31 | $24.98 Million | $-26.28 Million | -1.052x | -62.89% |
| 2021-12-31 | $57.78 Million | $-37.31 Million | -0.646x | +33.07% |
| 2020-12-31 | $40.12 Million | $-38.70 Million | -0.965x | -298.68% |
| 2019-12-31 | $22.86 Million | $11.10 Million | 0.486x | +149.18% |
| 2018-12-31 | $20.00 Million | $-19.75 Million | -0.988x | -1480.00% |
| 2017-12-31 | $21.49 Million | $-1.34 Million | -0.063x | +98.09% |
| 2016-12-31 | $8.34 Million | $-27.29 Million | -3.273x | -137.01% |
| 2015-12-31 | $14.88 Million | $-20.55 Million | -1.381x | -79.96% |
| 2014-12-31 | $18.52 Million | $-14.21 Million | -0.767x | -52.62% |
| 2013-12-31 | $30.72 Million | $-15.45 Million | -0.503x | -35.85% |
| 2012-12-31 | $36.33 Million | $-13.45 Million | -0.370x | +92.60% |
| 2011-12-31 | $3.48 Million | $-17.39 Million | -5.000x | -1033.13% |
| 2010-12-31 | $14.49 Million | $7.76 Million | 0.536x | +170.31% |
| 2009-12-31 | $27.42 Million | $-20.89 Million | -0.762x | -194.20% |
| 2008-12-31 | $36.42 Million | $-9.43 Million | -0.259x | +51.04% |
| 2007-12-31 | $34.58 Million | $-18.30 Million | -0.529x | -106.69% |
| 2006-12-31 | $37.03 Million | $-9.48 Million | -0.256x | -53.89% |
| 2005-12-31 | $43.35 Million | $-7.21 Million | -0.166x | +86.23% |
| 2004-12-31 | $18.39 Million | $-22.21 Million | -1.208x | -183.08% |
| 2003-12-31 | $45.12 Million | $-19.25 Million | -0.427x | +9.82% |
| 2002-12-31 | $66.18 Million | $-31.31 Million | -0.473x | -104.69% |
| 2001-12-31 | $97.05 Million | $-22.43 Million | -0.231x | -78.92% |
| 2000-12-31 | $115.25 Million | $-14.89 Million | -0.129x | +63.18% |
| 1999-12-31 | $20.73 Million | $-7.27 Million | -0.351x | -- |